Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740576019 | Heparinoid and lauromacrogol 400 only product in rectal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3740577011 | Product containing only heparinoid and lauromacrogol 400 in rectal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Has active ingredient | Heparinoid | true | Inferred relationship | Some | 1 | |
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Is a | Heparinoid- and lauromacrogol 400-containing product in rectal dose form | true | Inferred relationship | Some | ||
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Has active ingredient | Lauromacrogol-400 | true | Inferred relationship | Some | 2 | |
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Has manufactured dose form | Rectal dose form | true | Inferred relationship | Some | ||
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Is a | Heparinoid and lauromacrogol 400 only product | true | Inferred relationship | Some | ||
| Heparinoid and lauromacrogol 400 only product in rectal dose form | Plays role | Sclerosant therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment | Is a | True | Heparinoid and lauromacrogol 400 only product in rectal dose form | Inferred relationship | Some |
This concept is not in any reference sets